Mark L Gonzalgo
Mark L Gonzalgo
Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome? [0.03%]
亨伯特·赫夫列的膀胱癌：如果他能穿越时间，结局会有所不同吗？
Kevin R Loughlin
Kevin R Loughlin
Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management [0.03%]
有望重塑浅表性膀胱癌管理的未来关键临床试验
Paige Hargis,Hannah Baker,Brett Wiesen et al.
Paige Hargis et al.
High-risk non-muscle-invasive bladder cancer (HR-NMIBC) represents a biologically aggressive disease state with substantial risk of recurrence, progression, and need for radical cystectomy. While intravesical Bacillus Calmette-Guérin (BCG)...
Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care [0.03%]
未来展望：人工智能和数字工具在膀胱癌治疗中的应用
Tommy Jiang,Calvin C Zhao,Joseph C Liao
Tommy Jiang
This comprehensive review examines using artificial intelligence (AI) across the diagnostic, therapeutic, and prognostic landscape of bladder cancer. It highlights AI's capacity to enhance tumor detection, histopathologic interpretation, su...
Veerain K Gupta,Daniel D Joyce,Kevin M Wymer et al.
Veerain K Gupta et al.
Non-muscle invasive bladder cancer represents the majority of bladder cancer cases and imposes a significant economic burden due to high recurrence rates and intensive surveillance. Cost-effectiveness analyses help compare treatment strateg...
Melinda Z Fu,Jennifer Sykes,John Pfail et al.
Melinda Z Fu et al.
Approximately 75% to 80% of cases are nonmuscle-invasive bladder cancer (NMIBC), an often chronic condition with high recurrence rates necessitating lifelong surveillance and repeated interventions. Despite contemporary favorable 5-year can...
Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non-Muscle-Invasive Disease [0.03%]
社会和结构因素对膀胱癌预后的影响：非肌层浸润性膀胱癌为重点
Sha Zhu,Samuel L Washington rd,Rishi Sekar et al.
Sha Zhu et al.
Non-muscle-invasive bladder cancer (NMIBC) requires repeated procedures, long-term surveillance, and sustained access to urologic care. Outcomes are highly sensitive to health disparities. This article examines how social determinants of he...
Surveillance Protocols: Balancing Patient Burden and Cancer Control [0.03%]
surveillance Protocols：权衡患者负担与癌症控制
Heather Steckenrider,Jessica Delgado,Chad Ritch
Heather Steckenrider
Bladder cancer is the fourth most common cancer in males, and roughly 75% of new bladder cancer is non-muscle-invasive. Traditional surveillance protocols are costly and time-intensive for patients. Some studies report that more than half o...
Jacob E Tallman,Alvin C Goh
Jacob E Tallman
High-risk non-muscle-invasive bladder cancer represents a biologically heterogeneous disease with wide variation in recurrence and progression risk, creating persistent challenges in diagnosis, risk stratification, and management. Current g...
Molecular and Genetic Insights for Personalized Treatment of Non-Muscle-Invasive Bladder Cancer [0.03%]
非肌层浸润性膀胱癌的精准治疗分子机制及遗传学见解
Jose I Nolazco,Kendrick Yim,Keyan Salari
Jose I Nolazco
Nonmuscle-invasive bladder cancer (NMIBC) is a clinically heterogeneous disease, characterized by a high recurrence rate and a progression risk that are challenging to predict. Although traditional risk models based on histopathology and cl...